Is discussing 3Rs Helpful in Terms of Corporate Governance?
We hear from clients who are reticent about opening up the conversation about the replacement, reduction, and refinement (3Rs) of animal testing with their shareholders and customers. We understand the hesitation, but our experience with companies of any size is that this conversation results in greater trust and brand loyalty.
There are many benefits of authoring your own narrative on the 3Rs and this discussion has an even greater impact when the narrative is backed up by a third party certification.
Companies can disclose the percentage by which they reduced animal testing numbers. We have found that this number can be substantial and that disclosing it shows the real accomplishment made. We have Fortune 100 companies that have made huge strides in reducing animal experiments and have found that their brand is seen more favorably.
Next, as you may imagine, saving animal lives also has a corollary savings in cost. This number can also be quite appreciable. So, even for the shareholders and customers who have no interest in animal testing, an increase in profits and efficiency is appreciated.
Finally, with the addition of refinements and enrichments for each species, experiments have been shown to be less variable. Animals respond very differently under stress and extreme anxiety. Eliminating those physiological variations means that data will reflect experimental conditions rather than adding the variables of stress and inflammatory cascades in response to anxiety. Not only will the data be more convincing, but also fewer replicates will be needed, using fewer animals.